NUCOR CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data NUCOR CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	16,208	20,252	25,067	22,589	20,140	36,484	41,512	34,714	30,734	32,494
Cost of revenue	14,182	17,683	20,772	19,910	17,912	25,459	29,009	26,899	26,632	28,616
Gross profit	2,026	2,569	4,295	2,679	2,228	11,025	12,503	7,815	4,102	3,878
Selling, general and administrative	597	688	861	711	615	1,707	1,997	1,585	1,123	1,219
Interest expense	181	187	161	157	167	163	219	246	228	170
Interest income	11.9	13.7	25.7	35.9	13.4	4.27	49	276	258	111
Pre-tax income	1,299	1,750	3,229	1,783	836	9,201	10,245	6,273	2,902	2,568
Income tax	398	369	748	412	-0.49	2,078	2,166	1,360	583	530
Net income to minority interests	104	61.9	120	99.8	115	295	472	388	292	294
Net income	796	1,319	2,361	1,271	721	6,827	7,607	4,525	2,027	1,744
EPS, basic	2.48	4.11	7.44	4.14	2.37	23.23	28.88	18.05	8.47	7.53
EPS, diluted	2.48	4.10	7.42	4.14	2.36	23.16	28.79	18.00	8.46	7.52
Shares, basic (weighted)	320	320	316	305	303	292	262	250	238	231
Shares, diluted (weighted)	320	321	317	306	303	293	263	250	239	231
Dividend per share	1.50	1.51	1.54	1.60	1.61	1.72	2.01	2.07	2.17	2.21

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	2,046	949	1,399	1,535	2,640	2,365	4,281	6,383	3,558	2,260
Short-term investments	150	50	0	300	408	253	577	747	581	439
Receivables	1,632	2,029	2,506	2,160	2,299	3,854	3,591	2,953	2,675	3,105
Inventory	2,480	3,462	4,554	3,842	3,569	6,011	5,454	5,578	5,106	5,462
Other current assets	199	335	178	390	573	317	789	725	555	499
Total current assets	6,506	6,824	8,636	8,226	9,489	12,800	14,692	16,386	12,475	11,765
Property, plant and equipment	5,079	5,093	5,335	6,179	6,899	8,115	9,617	11,050	13,243	15,306
Lease right-of-use assets					93.9	92.3	101	103	107	118
Goodwill	2,053	2,196	2,184	2,201	2,230	2,827	3,920	3,969	4,288	4,297
Intangible assets	867	915	829	742	668	1,104	3,322	3,108	3,134	2,880
Other non-current assets	719	813	937	996	725	834	848	823	800	856
Total assets	15,224	15,841	17,921	18,345	20,125	25,823	32,479	35,340	33,940	35,104
Accounts payable	838	1,181	1,428	1,202	1,432	1,974	1,650	2,020	1,832	1,890
Accrued liabilities	505	574	611	660	664	965	948	1,056	975	1,020
Deferred revenue		72.3	91.2	109	120	252	285	314	200	243
Short-term debt	600	500	57.9	20	10.9	601	10	60	1,025	66
Total current liabilities	2,390	2,825	2,806	2,464	2,628	5,157	4,330	4,595	4,977	4,004
Long-term debt	3,739	3,242	4,233	4,291	5,272	4,961	6,614	6,649	5,683	6,909
Lease liabilities					75.7	74.2	81.5	82	93	102
Total liabilities	6,969	6,756	7,719	7,553	8,894	11,219	12,909	13,217	12,523	12,980
Total debt	4,361	3,742	4,233	20	5,283	601	10	60	1,025	66
Paid-in capital	1,975	2,021	2,074	2,108	2,121	2,141	2,144	2,176	2,223	2,253
Retained earnings	7,631	8,464	10,337	11,115	11,344	17,674	24,755	28,762	30,271	31,504
Treasury stock	-1,560	-1,643	-2,467	-2,714	-2,710	-5,835	-8,498	-9,988	-12,144	-12,779
Other comprehensive income	-318	-255	-304	-303	-119	-115	-137	-162	-208	-194
Shareholders' equity	7,880	8,739	9,792	10,358	10,789	14,016	18,415	20,940	20,294	20,936
Minority interests	375	346	410	433	443	587	1,155	1,183	1,123	1,188
Total equity	8,255	9,085	10,202	10,791	11,232	14,604	19,570	22,123	21,417	22,124
Total liabilities and equity	15,224	15,841	17,921	18,345	20,125	25,823	32,479	35,340	33,940	35,104

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	900	1,381	2,481	1,371	836	7,122	8,079	4,913	2,319	2,038
Depreciation and amortization	613	636	631	649	702	735	827	931	1,094	1,226
Stock-based compensation	56.5	64.2	73.4	90.4	73.9	136	137	130	132	133
Deferred income tax	71.5	-221	3.02	99.2	163	11.7	-47	21	-116	161
Change in receivables	-218	-330	-485	361	-129	-1,392	501	664	319	-428
Change in inventory	-133	-901	-1,092	713	284	-2,307	962	-75	518	-366
Change in payables	237	315	236	-253	251	383	-496	361	-321	80
Cash from operations	1,750	1,055	2,394	2,809	2,697	6,231	10,072	7,112	3,979	3,234
Capital expenditures	-605	-449	-983	-1,477	-1,543	-1,622	-1,948	-2,214	-3,173	-3,422
Acquisitions	-475	-544	-33.1	-83.1	-88.1	-1,426	-3,553	-71	-758	-2
Purchases of investments	-650	-50		-368	-489	-494	-914	-1,472	-1,296	-985
Sales and maturities of investments	600	150	50	67.7	392	649	590	1,317	1,487	1,140
Cash from investing	-1,025	-919	-1,030	-1,794	-1,764	-2,874	-5,703	-2,496	-3,734	-3,226
Debt issued			996		1,238	197	2,092			1,217
Debt repaid		-600	-500		-97.2		-1,111	-10	-10	-1,015
Stock issued	15.7	7.07	24.1	16.1	11.8	145	23	12	4	5
Share buybacks	-5.17	-90.3	-854	-299	-39.5	-3,276	-2,763	-1,554	-2,217	-700
Dividends paid	-481	-485	-485	-492	-492	-483	-534	-515	-522	-512
Cash from financing	-626	-1,242	-908	-880	286	-3,603	-2,511	-2,593	-3,058	-1,315
Exchange rate effect	8.04	9
Net change in cash	106	-1,097	450	136	1,220	-246	1,852	2,026	-2,829	-1,298
Free cash flow	1,145	607	1,411	1,332	1,154	4,609	8,124	4,898	806	-188
Interest paid	183	187	166	173	181	171	230	257	256	281
Income taxes paid	329	700	561	525	50.3	1,680	2,630	1,060	508

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 4, 2026; growth uses fiscal years. Valuation uses the share price of $247.25 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	15.5%	Gross profit / revenue.
Pre-tax margin	11.4%	Pre-tax income / revenue.
Net margin	8.0%	Net income / revenue.
FCF margin	4.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	12.3%	Cash from operations / revenue.
Effective tax rate	20.7%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	13.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	7.8%	Net income / average total assets.
SG&A / revenue	3.9%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	7.9%	Capital expenditures / revenue.
D&A / revenue	3.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	5.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-7.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	10.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-5.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-32.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	11.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-14.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-38.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	19.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-11.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-36.1%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	26.1%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-18.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-31.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	3.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-123.3%	Free cash flow vs the same period a year earlier. Only from a positive base.
Dividend per share growth, 1y	1.8%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	3.2%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	6.5%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	3.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	4.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	14.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	3.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	2.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	11.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-3.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-4.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-5.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.51x	Current assets / current liabilities.
Quick ratio	1.28x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.51x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.32x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	18.9%	Total debt / total assets.
Liabilities / assets	37.0%	Total liabilities / total assets.
Net debt	$4.28B	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	$7.91B	Current assets - current liabilities.
Goodwill and intangibles / assets	19.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	$15.07B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.98x	Revenue / average total assets.
Fixed asset turnover	2.28x	Revenue / average property, plant and equipment.
Inventory turnover	5.07x	Cost of revenue / average inventory.
Days inventory	72 days	365 x average inventory / cost of revenue.
Receivables turnover	8.92x	Revenue / average receivables.
Days sales outstanding	41 days	365 x average receivables / revenue.
Days payables	28 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	85 days	Days inventory + days sales outstanding - days payables.
FCF conversion	54.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	64.2%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$12.62	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$157.99	Revenue / diluted weighted shares.
FCF per share	$6.93	Free cash flow / diluted weighted shares.
Operating cash flow per share	$19.36	Cash from operations / diluted weighted shares.
Book value per share	$96.76	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$65.93	Tangible book value / shares outstanding.
Cash per share	$11.78	(Cash + short-term investments) / shares outstanding.
Payout ratio	17.8%	Dividends paid / net income, when net income is positive.
Dividends / FCF	32.3%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	42.6%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$56.10B	Share price x shares outstanding.
Enterprise value	$60.37B	Market cap + total debt - cash - short-term investments.
P/E	19.5x	Market cap / net income. Only when net income is positive.
P/S	1.55x	Market cap / revenue.
P/B	2.54x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.72x	Market cap / tangible book value, when positive.
P/FCF	35.4x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	12.7x	Market cap / cash from operations, when positive.
EV/Sales	1.67x	Enterprise value / revenue.
EV/FCF	38.1x	Enterprise value / free cash flow, when both are positive.
FCF yield	2.8%	Free cash flow / market cap.
Earnings yield	5.1%	Net income / market cap (the inverse of P/E).
Dividend yield	0.9%	Dividends paid over the period / market cap.
Shareholder yield	2.1%	(Dividends paid + share buybacks) / market cap.

What was NUCOR CORP's revenue in fiscal 2025?

NUCOR CORP reported revenue of $32.49B for fiscal 2025, 5.7% higher than the year before.

Was NUCOR CORP profitable in fiscal 2025?

Yes. Net income was $1.74B, a net margin of 5.4%.

How much free cash flow did NUCOR CORP generate in fiscal 2025?

Cash from operations of $3.23B minus capital expenditures of $3.42B left free cash flow of -$188.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to NUCOR CORP